197 related articles for article (PubMed ID: 35977467)
21. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
[TBL] [Abstract][Full Text] [Related]
22. H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice.
Margine I; Hai R; Albrecht RA; Obermoser G; Harrod AC; Banchereau J; Palucka K; García-Sastre A; Palese P; Treanor JJ; Krammer F
J Virol; 2013 Apr; 87(8):4728-37. PubMed ID: 23408625
[TBL] [Abstract][Full Text] [Related]
23. Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers.
Bean R; Giurgea LT; Han A; Czajkowski L; Cervantes-Medina A; Gouzoulis M; Mateja A; Hunsberger S; Reed S; Athota R; Baus HA; Kash JC; Park J; Taubenberger JK; Memoli MJ
mBio; 2024 Feb; 15(2):e0237223. PubMed ID: 38193710
[TBL] [Abstract][Full Text] [Related]
24. Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.
Klausberger M; Tscheliessnig R; Neff S; Nachbagauer R; Wohlbold TJ; Wilde M; Palmberger D; Krammer F; Jungbauer A; Grabherr R
PLoS One; 2016; 11(4):e0153579. PubMed ID: 27088239
[TBL] [Abstract][Full Text] [Related]
25. Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay.
Chromikova V; Tan J; Aslam S; Rajabhathor A; Bermudez-Gonzalez M; Ayllon J; Simon V; García-Sastre A; Salaun B; Nachbagauer R; Krammer F
Vaccine; 2020 Feb; 38(8):1953-1961. PubMed ID: 31959425
[TBL] [Abstract][Full Text] [Related]
26. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
[TBL] [Abstract][Full Text] [Related]
27. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
[TBL] [Abstract][Full Text] [Related]
28. Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
Prachanronarong KL; Canale AS; Liu P; Somasundaran M; Hou S; Poh YP; Han T; Zhu Q; Renzette N; Zeldovich KB; Kowalik TF; Kurt-Yilmaz N; Jensen JD; Bolon DNA; Marasco WA; Finberg RW; Schiffer CA; Wang JP
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381484
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus.
Park JK; Han A; Czajkowski L; Reed S; Athota R; Bristol T; Rosas LA; Cervantes-Medina A; Taubenberger JK; Memoli MJ
mBio; 2018 Jan; 9(1):. PubMed ID: 29362240
[TBL] [Abstract][Full Text] [Related]
30. Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.
Freyn AW; Han J; Guthmiller JJ; Bailey MJ; Neu K; Turner HL; Rosado VC; Chromikova V; Huang M; Strohmeier S; Liu STH; Simon V; Krammer F; Ward AB; Palese P; Wilson PC; Nachbagauer R
Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33593910
[TBL] [Abstract][Full Text] [Related]
31. Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase.
Lei R; Kim W; Lv H; Mou Z; Scherm MJ; Schmitz AJ; Turner JS; Tan TJC; Wang Y; Ouyang WO; Liang W; Rivera-Cardona J; Teo C; Graham CS; Brooke CB; Presti RM; Mok CKP; Krammer F; Dai X; Ellebedy AH; Wu NC
Immunity; 2023 Nov; 56(11):2621-2634.e6. PubMed ID: 37967533
[TBL] [Abstract][Full Text] [Related]
32. Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies.
Arevalo CP; Le Sage V; Bolton MJ; Eilola T; Jones JE; Kormuth KA; Nturibi E; Balmaseda A; Gordon A; Lakdawala SS; Hensley SE
Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17221-17227. PubMed ID: 32631992
[TBL] [Abstract][Full Text] [Related]
33. Promises and challenges of single-domain antibodies to control influenza.
Matthys A; Saelens X
Antiviral Res; 2024 Feb; 222():105807. PubMed ID: 38219914
[TBL] [Abstract][Full Text] [Related]
34. Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies.
Job ER; Ysenbaert T; Smet A; Van Hecke A; Meuris L; Kleanthous H; Saelens X; Vogel TU
mBio; 2019 Oct; 10(5):. PubMed ID: 31641082
[TBL] [Abstract][Full Text] [Related]
35. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
36. Assessment of Influenza Virus Hemagglutinin Stalk-Specific Antibody Responses.
Liu WC; Nachbagauer R; Krammer F; Albrecht RA
Methods Mol Biol; 2018; 1836():487-511. PubMed ID: 30151588
[TBL] [Abstract][Full Text] [Related]
37. The Potential of Neuraminidase as an Antigen for Nasal Vaccines To Increase Cross-Protection against Influenza Viruses.
Kawai A; Yamamoto Y; Nogimori T; Takeshita K; Yamamoto T; Yoshioka Y
J Virol; 2021 Sep; 95(20):e0118021. PubMed ID: 34379511
[TBL] [Abstract][Full Text] [Related]
38. Assessing the Protective Potential of H1N1 Influenza Virus Hemagglutinin Head and Stalk Antibodies in Humans.
Christensen SR; Toulmin SA; Griesman T; Lamerato LE; Petrie JG; Martin ET; Monto AS; Hensley SE
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700610
[TBL] [Abstract][Full Text] [Related]
39. H9N2 Influenza Virus Infections in Human Cells Require a Balance between Neuraminidase Sialidase Activity and Hemagglutinin Receptor Affinity.
Arai Y; Elgendy EM; Daidoji T; Ibrahim MS; Ono T; Sriwilaijaroen N; Suzuki Y; Nakaya T; Matsumoto K; Watanabe Y
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641475
[TBL] [Abstract][Full Text] [Related]
40. Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies.
Kosik I; Angeletti D; Gibbs JS; Angel M; Takeda K; Kosikova M; Nair V; Hickman HD; Xie H; Brooke CB; Yewdell JW
J Exp Med; 2019 Feb; 216(2):304-316. PubMed ID: 30683737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
